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IgE binds asymmetrically to its B 
cell receptor CD23
Balvinder Dhaliwal1, Marie O. Y. Pang2,3, Anthony H. Keeble2,3,†, Louisa K. James2,3,‡, 
Hannah J. Gould2,3, James M. McDonnell2,3, Brian J. Sutton2,3 & Andrew J. Beavil2,3
The antibody IgE plays a central role in allergic disease mechanisms. Its effector functions are controlled 
through interactions between the Fc region and two principal cell surface receptors FcεRI and CD23. The 
interaction with FcεRI is primarily responsible for allergic sensitization and the inflammatory response, 
while IgE binding to CD23 is involved in the regulation of IgE synthesis and allergen transcytosis. Here 
we present the crystal structure of a CD23/IgE-Fc complex and conduct isothermal titration calorimetric 
binding studies. Two lectin-like “head” domains of CD23 bind to IgE-Fc with affinities that differ by more 
than an order of magnitude, but the crystal structure reveals only one head bound to one of the two 
identical heavy-chains in the asymmetrically bent IgE-Fc. These results highlight the subtle interplay 
between receptor binding sites in IgE-Fc and their affinities, the understanding of which may be 
exploited for therapeutic intervention in allergic disease.
An estimated 40% of the population suffer from at least one form of allergy, with their prevalence continuing 
to soar worldwide1. Allergic diseases, which include allergic rhinitis (‘hay fever’), respiratory allergy (e.g. atopic 
asthma) and food allergy, have a detrimental impact on a person’s quality of life2–5, a nation’s economy6,7, and in 
acute cases can be life threatening8.
The antibody immunoglobulin E (IgE) plays a central role in allergic disease mechanisms. For reasons poorly 
understood, IgE recognizes seemingly innocuous substances known as allergens via its Fab regions, whilst its 
effector functions are controlled through interactions of the Fc region with two principal cell surface receptors, 
Fcε RI and CD23 (also known as Fcε RII)9,10. Fcε RI, found on mast cells and basophils, binds IgE with high affinity 
(KD of 0.01 to 0.1 nM)11 and is responsible for allergic sensitization and the immediate hypersensitivity response 
in which minute amounts of allergen crosslink Fcε RI-bound IgE triggering cellular degranulation, release of 
proinflammatory mediators such as histamine and the initiation of an allergic response12.
The second receptor for IgE, CD23, is unique among Ig receptors in that it belongs to the C-type lectin-like 
superfamily13. Expressed in several hematopoietic cell types, including B cells and antigen-presenting cells, in its 
membrane-bound form CD23 consists of three C-type lectin ‘head’ domains connected to the membrane by a 
trimeric α -helical coiled-coil ‘stalk’14. A single head domain binds to human IgE-Fc with an affinity KD of ~1 μ M15, 
although avidity of the trimer16–19 and the presence of Ca2+ 15,20 can substantially enhance the interaction. The 
stalk region of CD23 is susceptible to attack by endogenous proteases such as ADAM1021, releasing soluble tri-
meric and monomeric forms of CD23. The house dust mite allergenic protease Der p 1 generates a soluble mon-
omeric form of CD23 consisting of just the lectin head domain, termed derCD2322.
The interaction of CD23 with IgE is involved in regulating many allergic processes23. For example, when 
expressed on epithelial cells, CD23 is involved in the transportation of IgE-allergen immune complexes across 
the gut24 and airways25. On B cells that have switched to IgE production, the CD23-IgE interaction is critical to 
both the up- and down-regulation of IgE synthesis depending on the oligomeric form of CD239. This interaction 
is also essential in the process of facilitated antigen presentation (FAP)9, in which IgE-allergen complexes are 
internalized by CD23 on antigen-presenting cells. The allergen is then proteolytically cleaved and its peptides 
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complexed with MHC class II molecules and recycled to the cell surface for Type 2 helper (TH2) cell recognition 
and activation. The activated TH2 cells secrete cytokines that ultimately lead to an increase in IgE synthesis and 
exacerbation of allergic inflammation26,27. Recent evidence indicates that the CD23 surface density on B cells 
determines its FAP activity28. The CD23-IgE interaction is thus involved in both the development and regulation 
of the allergic response, and indeed, molecules designed to target the interaction such as the anti-CD23 IgG anti-
body Lumiliximab and DARPins have been shown to inhibit IgE synthesis29,30. A molecular understanding of the 
CD23-IgE interaction thus has implications for the control of allergic disease.
We previously reported the crystal structure of derCD23 in complex with Fcε 3-431, a subfragment of IgE-Fc 
consisting of a dimer of the Cε 3 and Cε 4 domains. One head domain was found to bind to each heavy chain of 
IgE, principally to the Cε 3 domains but with a contribution from Cε 4, explaining the known 2:1 stoichiometry 
of monomeric CD23 binding to both IgE-Fc and Fcε 3-419,32. Although the binding sites for Fcε RI and CD23 lie 
at opposite ends of the Cε 3 domain, we went on to demonstrate that the binding of the two receptors to IgE are 
allosterically linked and mutually exclusive, with conformational changes in Fcε 3-4 upon CD23 binding preclud-
ing the binding of Fcε RI and vice versa31.
Here we present the crystal structure of derCD23 in complex with the complete IgE-Fc region, including 
the Cε 2 domains, which in the free molecule fold back onto the Fcε 3-4 region in an asymmetrical fashion33. 
One derCD23 molecule is seen binding to one IgE-Fc chain, making contact with all three domains. Isothermal 
titration calorimetry (ITC) experiments confirm the 2:1 (derCD23:IgE-Fc) stoichiometry in solution and reveal 
that the two binding affinities differ by more than an order of magnitude; this is explained in terms of the crystal 
structure.
Results
Quaternary structure of the derCD23/IgE-Fc complex. The crystal structure contains two essentially 
identical complexes of derCD23/IgE-Fc within the asymmetric unit. Each complex consists of one IgE-Fc mol-
ecule bound to one molecule of derCD23 (Fig. 1). The derCD23 molecule interacts with the IgE-Fc chain onto 
which the Cε 2 domains are folded back. The 1:1 stoichiometry of the complex (i.e., one IgE-Fc dimer bound to 
one molecule of derCD23) was unexpected, as it is well documented that one CD23 head domain binds to each 
heavy chain of IgE, whether the Fcε 3-4 sub-fragment or the complete IgE-Fc15,19,31,32.
The derCD23/IgE-Fc interface. The derCD23 molecule binds principally to the Cε 3 domain with lesser 
interactions with Cε 4 and the short Cε 3-Cε 4 linker region. The interface is predominantly hydrophilic, consist-
ing of five salt bridges with hydrogen bonds, and six additional hydrogen bonds (Fig. 2). The majority of these 
interactions are similar to those observed at the interface of the derCD23/Fcε 3-4 crystal structure31, as well as 
being consistent with NMR chemical shift perturbation studies and binding experiments using proteins with 
mutated interface residues34. There is an additional interaction between Asp258 of CD23 and Arg440 in the Cε 
3-Cε 4 linker, an interaction that had only previously been observed in the Ca2+-bound derCD23/Fcε 3-4 crystal 
structure (Figure S1). In the absence of Ca2+ binding to CD23, as in the complex presented here, the loop includ-
ing Asp258 is found to be partially flexible20,31,35,36. Despite the close approach of derCD23 to the Cε 2 domain in 
the same heavy chain, just a single hydrogen bond is observed between His216 of derCD23 and Thr260 of Cε 2 
(Figs 1 and 2).
The derCD23/IgE-Fc interface shows an even poorer surface complementarity37 than that found in the 
derCD23/Fcε 3-4 complex; the calculated Sc values38 range between 0.49–0.51 for the former, compared to 0.63–
0.71 for the latter (the range of values refers to the different molecular complexes in the asymmetric unit). The 
Figure 1. Structure of the 1:1 derCD23/IgE-Fc complex. The derCD23 (green Cα traces with surfaces) 
binds to one heavy chain of IgE-Fc (red and blue) contacting the Cε 3 and Cε 4 domains. The Cε 2 domains 
are asymmetrically bent back onto one Cε 3 domain and make some additional contacts with derCD23. The 
carbohydrate is shown in all-atom representation (red and yellow, without surfaces) and can be seen behind the 
Cε 3 domain.
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buried surface area of the derCD23/IgE-Fc interface ranges from 965 to 1042 Å2, with relative contributions from 
the Cε 2 domain of 24%, the Cε 3 domain 56%, the Cε 3-Cε 4 linker (Ser437 to Arg440) 10%, and the Cε 4 domain 
10%. The Cε 2-Cε 3 linker (Lys326 to Ser337) does not contribute to the interface. Relatively few well-defined 
residues are involved in the network of van der Waals contacts at the interface (Gly180, Trp184, Val185, Phe272 
and Asp274 in derCD23; Phe321, Ser378, Lys380, Ile411 and Lys435 in IgE-Fc). Of these hydrophobic interac-
tions, only one involves the Cε 2 domain: Phe321 interacts with Gly180 of derCD23. No interactions are observed 
between derCD23 and the other IgE-Fc heavy chain.
Comparison with previous IgE-Fc structures. IgE-Fc strongly favors an asymmetrically bent structure 
in its free state39, with the Cε 2 domain pair folded back and making contact not only with one of the Cε 3 domains 
but also Cε 433. Previous modeling of the derCD23/IgE-Fc complex by docking the (Cε 2)2 domain pair from the 
free IgE-Fc structure onto the derCD23/Fcε 3-4 complex had suggested that only minor rearrangements of a few 
N-terminal residues in the Cε 2 domain were required to prevent a steric clash with derCD2331. However, the 
experimentally determined complex shows that upon binding of a single derCD23 molecule, the disulfide-linked 
(Cε 2)2 domain pair move as a rigid unit, swinging out 16° to accommodate the derCD23 molecule (Fig. 3 and 
Supplementary movie).
Figure 2. Salt bridges and hydrogen bonds at the derCD23/IgE-Fc interface. The five H-bonds associated 
with salt bridges in both independent complexes are shown in red, and the six remaining H-bonds are shown in 
black.
Figure 3. Orthogonal views depicting conformational changes in IgE-Fc upon binding a single molecule of 
derCD23 (not shown). A substantial rigid body movement of the IgE-Fc Cε 2 domains upon derCD23 binding 
is observed when compared to free IgE-Fc (yellow and green). In addition, the Cε 3 domain in the derCD23-
bound chain (red) adopts an extreme closed conformation, in contrast to the Cε 3 domain in the free chain 
(blue), which adopts an extreme open conformation. The structures were superposed on their (Cε 4)2 domains.
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The Fcε 3-4 moiety of the IgE-Fc dimer in the complex also adopts a surprising conformation upon derCD23 
binding. Flexibility in the Cε 3-Cε 4 interdomain angle has been well documented in both unliganded Fcε 3-440,41 
and IgE-Fc33, and in complex with sFcε RIα 11,42 or derCD2320,31,36. A comparison of all previous Fcε 3-4 and IgE-Fc 
structures shows that the Cε 3-Cε 4 angle varies over a range of 25°, with IgE-Fc or Fcε 3-4 in complex with sFcε RIα 
adopting the most ‘open’ conformation for the Cε 3 domains, and Fcε 3-4 in complex with derCD23 adopting the 
most ‘closed’ conformation. Examination of the Cε 3-Cε 4 interdomain angles of IgE-Fc in complex with derCD23 
presented here reveals that the chain bound to derCD23 adopts a closed conformation. In contrast, the free IgE-Fc 
chain unexpectedly adopts a very open conformation; indeed, the Cε 3-Cε 4 interdomain angles of the two chains 
differ by 16° (Figure S2). Comparison of the two IgE-Fc chains in the complex with all other IgE-Fc and Fcε 3-4 
structures shows that the derCD23-bound IgE-Fc chain has the same closed Cε 3-Cε 4 interdomain angle previ-
ously observed in the Ca2+-free derCD23-Fcε 3-4 complex crystallized in space group P136 (Figure S2). This closed 
conformation is clearly incompatible with Fcε RI binding31,42. The free IgE-Fc chain, on the other hand, adopts the 
most open conformation observed, the same conformation previously only seen in complex with sFcε RIα 11,42. 
Earlier structural studies had indicated that free IgE-Fc chains favoured an intermediate position between the 
open and closed conformations33, however our results reveal that the free chain of IgE-Fc adopts an extremely 
open conformation when the other chain is bound to derCD23: clearly a conformational change involving a clos-
ing of the Cε 3-Cε 4 interdomain angle is required to bind a second derCD23 molecule (Figure S3).
The two CD23 binding sites on IgE have different affinities. The binding affinity of derCD23 to 
IgE-Fc was determined using ITC, by titrating derCD23 into a fixed concentration of IgE-Fc. The data fitted best 
to a two-site binding model (Figure S4). One binding site has an affinity of 1.2 μ M (KD1; Table 1), while the other 
is over an order of magnitude (12-fold) weaker with an affinity of 14.4 μ M (KD2).
Discussion
The interaction of CD23 and IgE is critical in many allergic disease processes, including the regulation of IgE syn-
thesis, facilitated allergen presentation and allergen transportation across the gut and airways. Here we present the 
crystal structure of a lectin-like head domain of CD23 in complex with the complete Fc receptor-binding region 
of IgE. The results of ITC experiments reported here confirm the 2:1 stoichiometry reported earlier19,32, but now 
reveal that the affinities for the two sites, one in each heavy chain, are very different (KD = 1.2 μ M and 14.4 μ M), 
with distinct thermodynamic profiles (Table 1). This is consistent with results from an earlier sedimentation equi-
librium study of derCD23 binding to Fcε 3-4, which concluded that the two sites were thermodynamically distinct, 
with a greater enthalpy change for one site than the other, although the affinities were similar (KD ~ 10 μ M)36. 
The work reported here investigates the effect upon CD23 binding of the Cε 2 domains in the complete IgE-Fc, 
which is known to have an acutely and asymmetrically bent structure in the free state33.
The crystal structure of derCD23 bound to IgE-Fc unexpectedly revealed only a 1:1 complex, with the sin-
gle derCD23 molecule bound principally to the heavy chain onto which the Cε 2 domains are folded back. The 
derCD23 molecule primarily contacts Cε 3 and, as in the complexes with Fcε 3-420,31,36, also contacts Cε 4 and 
the Cε 3-Cε 4 linker region; in addition however, there are a few contacts with Cε 2 including a single hydrogen 
bond. The binding of this derCD23 molecule is also accompanied by a swinging out of the Cε 2 domain pair (an 
“unbending” of the IgE-Fc) by 16°. Another aspect of the asymmetry of the IgE-Fc is the difference in the Cε 3-Cε 
4 interdomain angle in the 1:1 complex: in the chain to which derCD23 is bound the angle is closed (as seen in the 
complexes with Fcε 3-4), whereas in the other, free chain, the angle is very open and incompatible with derCD23 
binding. This is in contrast to the earlier Fcε 3-4 complexes in which two derCD23 molecules were bound sym-
metrically to the two chains, both of which adopted a closed interdomain conformation. Clearly further confor-
mational changes must occur upon binding of a second derCD23 molecule to IgE-Fc.
Despite the undoubted structural asymmetry between the two derCD23 binding sites in IgE-Fc, we cannot 
definitively assign the stronger and weaker affinity values to these sites. However, it is reasonable to assume that 
the derCD23 molecule seen in the crystal structure corresponds to the higher affinity site; it also has contribu-
tions from Cε 2 which could not occur at the site in the other heavy chain. In any event, the binding of the first 
derCD23 molecule at least preserves, and perhaps even exacerbates, the asymmetry in IgE-Fc and in particular 
the Cε 3-Cε 4 interdomain angle; if the latter, then binding to the first site may influence the affinity of the second 
site (Supplementary Figure S2 and Supplementary Movie). If there is “cross-talk” between the two sites, this is yet 
another example of communication between receptor binding sites in IgE-Fc, such as that for CD23 and Fcε RI. 
We have previously reported that the binding sites of CD23 and Fcε RI on IgE, although at opposite ends of the 
Cε 3 domain, are allosterically linked, whereby conformational changes in IgE upon CD23 binding preclude the 
binding of Fcε RI and vice versa31. Moreover, Ca2+-binding to CD23 causes local allosteric conformational changes 
that increase its affinity for IgE20.
Thus the CD23/IgE/Fcε RI network of interactions involves at least two and perhaps three allosteric mech-
anisms within IgE-Fc. Together these permit an extraordinarily intricate level of control of protein-protein 
interactions regulating many aspects of the allergic response. Mutual exclusion of Fcε RI and CD23 binding 
to IgE is essential to prevent mast cell and basophil activation by trimeric sCD23 in the absence of allergen31. 
Experiment KD1 (μM) ΔH1 (kcal/mol) −TΔS1 (kcal/mol) KD2 (μM) ΔH2 (kcal/mol) −TΔS2 (kcal/mol)
derCD23 titrated 
into IgE-Fc 1.2 ( ± 0.3) − 7.2 ( ± 0.4) − 0.9
14.4 
( ± 3.0) − 3.7 ( ± 0.6) − 3.0
Table 1.  Binding affinities of derCD23 to IgE-Fc studied by ITC.
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Conformational changes in CD23 on antigen-presenting cells, upon release of bound Ca2+, has recently been 
proposed to be involved in the mechanism that releases IgE/allergen complexes and recycles receptor back to 
the plasma membrane43. On B cells, cross-linking of membrane CD23 by soluble IgE, and/or the formation of 
extended arrays of mIgE cross-linked by soluble trimeric CD23 to create signaling platforms for the survival and 
differentiation of IgE-committed cells, have been proposed to control IgE homeostasis9. All of these interactions 
critically depend upon the concentrations and oligomeric states of CD23 and IgE and their mutual affinities. 
While this study extends our understanding of CD23 binding to IgE-Fc by including the Cε 2 domains and their 
associated conformational changes, it is important to consider the consequences of the presence of the IgE Fab 
arms, and also possible Fc glycosylation, for the interaction between the complete molecules. We have previously 
modelled the range of conformations available to the Fab arms in both free and Fcε RI-bound IgE, and found that 
they are more restricted than in IgG, occupying volumes that are mutually exclusive and distinct from the space 
occupied by the Fc region44,45. Thus the derCD23/IgE-Fc interaction that we observe in the crystal structure may 
indeed be extended to the whole IgE molecule. Regarding glycosylation, two sites on the surface of IgE-Fc (aspar-
agine residues 265 and 371) have been shown to be glycosylated46, and were mutated to glutamine in the construct 
used in this study to facilitate crystallization47. However, these attachment sites are distant from the CD23 binding 
site, and therefore unlikely to affect the interaction.
Extrapolation of the results presented here to the binding of either one or two complete CD23 trimers to IgE 
is also important. We have previously reported that the two head domains that engage Fcε 3-4 cannot come from 
the same trimer31, and this is equally true for IgE-Fc or the whole IgE molecule. However, taking all of the above 
structural considerations into account, it is also clear that two CD23 trimers can bind to one IgE molecule, or 
one CD23 trimer can cross-link two IgE molecules, either in the context of soluble trimeric CD23 binding to 
membrane IgE, or soluble IgE binding to membrane CD23, in relation to IgE regulation or allergen/IgE immune 
complex transcytosis. A detailed molecular understanding of the IgE/CD23 interaction may thus permit novel 
approaches to intervene therapeutically in allergic disease.
Methods
Protein purification. Recombinant human derCD23 (Ser156-Glu298) and IgE-Fc (Val224-Lys547, incor-
porating glycosylation double mutations N265Q and N371Q) proteins were expressed, refolded and purified 
according to protocols previously described15,31,32,47.
Crystallization and data collection. The derCD23-IgE-Fc complex was crystallized by vapor diffusion. 
IgE-Fc was concentrated to 37 mg/mL, and derCD23 to 18 mg/mL, both in 25 mM Tris·HCl (pH 7.5), 20 mM 
NaCl, 0.05% (w/v) sodium azide, followed by mixing of 0.56 mM derCD23 (8.6 mg/mL) with 0.28 mM IgE-Fc 
(20 mg/mL), and diluting the complex with an equal volume (100 nL) of 15% (w/v) PEG 8,000, 0.1 M sodium 
citrate, 0.05 M ammonium sulfate. A single needle-like crystal suitable for data collection grew after one and a half 
months at 295 K. The crystal was flash-cooled (using 18% (w/v) PEG 8,000, 0.1 M sodium citrate, 0.05 M ammo-
nium sulfate, 20% (v/v) glycerol as cryoprotectant) and stored in liquid nitrogen. Diffraction data were collected 
at 100 K at beamline I03, Diamond Light Source.
Structure solution and refinement. Indexing and integration of data were carried out with MOSFLM48,49, 
and merging of data performed using AIMLESS50. The derCD23-IgE-Fc complex was solved by molecular 
replacement using PHASER51; two copies of the Fcε 3-4 dimer were identified in the asymmetric unit, using chains 
A and B from the derCD23-Fcε 3-4 complex (PDB 4EZM)31. Subsequently, two sets of Cε 2 dimers (chains A and 
B, residues 235–325, PDB 2WQR)11 were located. Finally, two Ca2+-free derCD23 molecules (using PDB 4J6J)35 
were identified. Iterative cycles of refinement using PHENIX52, REFMAC553 and BUSTER-TNT54 alternated with 
manual model building with COOT55. The model was built into 2Fo–Fc composite omit, 2Fo–Fc and Fo–Fc electron 
density maps to minimize bias. Disruption of some disulfide bonds due to radiation damage was observed in the 
derCD23/IgE-Fc complex structure. Carbohydrate atoms were subsequently incorporated into the structures. 
During refinement, tight NCS restraints were initially used; these were gradually relaxed and finally local struc-
ture similarity restraints54 applied. TLS groups56 were identified using the TLSMD Web server57. Data processing 
and refinement statistics are provided in Supplementary Table S1. PISA58 and CONTACTS38 were used to analyze 
protein-protein interfaces, and DynDom59 was used for conformational change analysis. All of the structural 
figures presented were generated using PyMOL60.
Isothermal titration calorimetry. The derCD23 and IgE-Fc proteins were dialyzed overnight into 25 mM 
Tris·HCl (pH 7.4), 125 mM NaCl supplemented with 4 mM CaCl220. The experiment was carried out at 25 °C in 
an iTC200 microcalorimeter (Microcal, GE Healthcare). To measure the affinity of derCD23 to IgE-Fc, 260 μ M 
derCD23 was loaded in the syringe and titrated into 12.5 μ M of IgE-Fc dimer within the sample cell. Data analysis 
was carried out using the Origin software supplied with the machine using a 2:1 binding model. Values in paren-
theses in Table 1 indicate the standard deviation.
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